8月21日，Moderna盘中上涨6.65%，报144.5美元/股，成交额10.7亿美元。此前该股因mRNA癌症疫苗三期试验成功单日暴涨177%后，连续两个交易日遭获利回吐累计回落超25%，当日迎来技术性反弹。
消息面上，摩根大通将Moderna目标价从40美元大幅上调至77美元。此前已有多家投行密集调整评估：杰富瑞上调目标价至150美元，美银全球研究将评级从"跑输大盘"升至"中性"并将目标价提升至170美元，Piper Sandler调整目标价至167美元。期权市场方面，当日出现2535万美元双卖Call组合及611万美元远月Put卖出等千万级大单，整体情绪偏多，隐含波动率百分位达99.6%极高水平。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.